Phase I study of vinblastine and temsirolimus in pediatric patients with recurrent or refractory solid tumors: Canadian Cancer Trials Group Study IND.218. [electronic resource]
Producer: 20191112Description: e27540 p. digitalISSN:- 1545-5017
- Adolescent
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Canada
- Child
- Drug Resistance, Neoplasm
- Female
- Follow-Up Studies
- Humans
- Male
- Maximum Tolerated Dose
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasms -- drug therapy
- Prognosis
- Salvage Therapy
- Sirolimus -- administration & dosage
- Survival Rate
- Vinblastine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.